Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Partners AG
Total Receivables Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Total Receivables
CHf3.4m
CAGR 3-Years
-25%
CAGR 5-Years
9%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Total Receivables
$25.2m
CAGR 3-Years
162%
CAGR 5-Years
71%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Receivables
CHf1.6m
CAGR 3-Years
20%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Receivables
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Total Receivables
CHf48.9m
CAGR 3-Years
16%
CAGR 5-Years
13%
CAGR 10-Years
15%
Kuros Biosciences AG
SIX:KURN
Total Receivables
CHf11m
CAGR 3-Years
71%
CAGR 5-Years
68%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Total Receivables?
Total Receivables
3.4m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Total Receivables amounts to 3.4m CHF.

What is Molecular Partners AG's Total Receivables growth rate?
Total Receivables CAGR 5Y
9%

Over the last year, the Total Receivables growth was 123%. The average annual Total Receivables growth rates for Molecular Partners AG have been -25% over the past three years , 9% over the past five years .

Back to Top